VERA
VERA
NASDAQ · Biotechnology

Vera Therapeutics Inc

$40.53
-0.84 (-2.03%)
As of Mar 22, 9:58 PM ET ·
Financial Highlights (FY 2025)
Revenue
672.08M
Net Income
-5,512,106
Gross Margin
40.0%
Profit Margin
-0.8%
Rev Growth
+20.0%
D/E Ratio
0.79
Revenue & Net Income
Margin Trends
FY 2025 FY 2024 FY 2023
Gross Margin 40.0% 40.0% 40.0%
Operating Margin -0.9% -0.9% -0.8%
Profit Margin -0.8% -0.7% -0.8%
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 672.08M 640.49M 736.20M
Gross Profit 268.89M 256.25M 294.54M
Operating Income -5,987,666 -5,750,446 -6,046,585
Net Income -5,512,106 -4,610,660 -5,991,019
Gross Margin 40.0% 40.0% 40.0%
Operating Margin -0.9% -0.9% -0.8%
Profit Margin -0.8% -0.7% -0.8%
Rev Growth +20.0% +11.6% +0.9%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 1.09B 885.45M 1.19B
Total Equity 1.39B 1.26B 1.32B
D/E Ratio 0.79 0.70 0.90
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA -7,633,568 -6,751,763 -9,172,286
Free Cash Flow -4,482,853 -2,925,974 -4,789,156